questionText: To ask the Secretary of State for Health and Social Care, whether his Department has asked the Advisory Council on the Misuse of Drugs to consider patient safety issues in its review of cannabis-based products for medicinal use, including prescribing to patients with serious mental illness, advertising by private clinics, prescribing volume oversight and cross-regulatory accountability.
answerText: The Department of Health and Social Care has worked closely with the Home Office and the Medicines and Healthcare products Regulatory Agency (MHRA) in the development and implementation of the law change in 2018 to permit the prescribing of unlicensed can...
heading: Cannabis: Medical Treatments